Disjunction Between Patient Narrative and Formulaic Thinking in the Doctor

NCT ID: NCT05401981

Last Updated: 2025-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is seeking whether giving or not giving a clinician a card with talking points in the form of a checklist about the patient's story affects the patients care experience or not

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During an office visit, the clinician and the patient engage in dialogue and begin a relationship. This traditionally starts with the patient telling their story, which conveys why they decided to seek care. This study will determine the influence of a checklist specifically about the patient's narrative. The checklist will be used during the interview portion of the visit, to remind the clinician to stay curious about the person before them, their experience of the illness, and their explanatory model, and to help ensure that empathic opportunities are not missed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Musculoskeletal Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel Assignment
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Participants will randomly be assigned to 2 groups of intervention (The clinician receives the check list) and control (The clinician doesn't receive a checklist). After the visit patients will answer to questionnaires .

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard care

Clinician not given any cards about the patient's story.

Group Type NO_INTERVENTION

No interventions assigned to this group

Story checklist

Clinician given a card with talking points in the form of a checklist about the patient's story.

Group Type EXPERIMENTAL

Story checklist

Intervention Type OTHER

The story checklist consists of a couple of questions that gives the physician something to keep in mind while visiting the patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Story checklist

The story checklist consists of a couple of questions that gives the physician something to keep in mind while visiting the patients.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* New patients
* Orthopedic visit

Exclusion Criteria

* Languages other than English or Spanish.
* Cognitive dysfunction precluding completion of questionnaires.
Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Texas at Austin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David Ring

David Ring, MD, PhD Associate Dean for Comprehensive Care, Professor of Surgery and Psychiatry

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Ring, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Texas at Austin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Austin Regional Clinic

Austin, Texas, United States

Site Status

Texas Orthopedics

Austin, Texas, United States

Site Status

HTB Musculoskeletal Institute

Austin, Texas, United States

Site Status

Orthopedic Specialists of Austin

Austin, Texas, United States

Site Status

ATX Ortho

Austin, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-01-0115

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cortisone Shots for Neck Pain
NCT03534531 COMPLETED